After 19 years at the US National Institute of Neurological Disorders and Stroke (NINDS), Story Landis retired last month. During her time there, she was struck by a transformation of neurological research on many fronts, including the discovery of disease-linked genes and the development of induced pluripotent stem cell models of disease. But a recent study of NINDS grants shows that funding of basic neurological research has also declined during this time, putting future advances at risk. Landis tells Asher Mullard about how she has worked to put the NINDS back on track before stepping down.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Rights and permissions
About this article
Cite this article
Story Landis. Nat Rev Drug Discov 13, 718–719 (2014). https://doi.org/10.1038/nrd4454
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd4454
This article is cited by
-
A plan for sustainable funding for US biomedical research
Nature Reviews Drug Discovery (2015)
